Apr 06, 2026
1:5
For every 5 shares held, investors received 1.
The split itself did not change the total investment value.
XORTX Therapeutics Inc. (GETTEX:A427MJ) operates in the Pharmaceuticals: major industry.
XORTX Therapeutics Inc. company overviewXORTX Therapeutics Inc.'s most recent stock split was on April 6, 2026. It was a 1-for-5 reverse split, so shareholders received 1 share for every 5 they held.
XORTX Therapeutics Inc. (GETTEX:A427MJ) has split its stock 3 times: a 1-for-4 reverse split on January 11, 2018, a 1-for-9 reverse split on November 14, 2023, and a 1-for-5 reverse split on April 6, 2026.
XORTX Therapeutics Inc. has split its stock 3 times. This history records 3 reverse splits between January 11, 2018 and April 6, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In XORTX Therapeutics Inc.'s 1-for-5 reverse split on April 6, 2026, every 5 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
XORTX Therapeutics Inc. has not announced a new split in our records. Its most recent split was on April 6, 2026, less than a year ago. Companies announce splits in advance, and any new GETTEX:A427MJ split will appear on this page.
Already premium?